Warsaw Medical University, Independent Public Clinical Hospital
Welcome,         Profile    Billing    Logout  
 1 Trial 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zieniewicz, Krzysztof
INTERLIVER, NCT03193151: Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting
N/A
300
Europe, Canada, US, RoW
liver biopsy
University of Alberta
Liver Dysfunction
12/25
12/26
CHANCE, NCT04613921: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs

Recruiting
N/A
3000
Europe, Canada, Japan, US, RoW
Observational Protocol
European Foundation for Study of Chronic Liver Failure
Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
12/25
12/26
Grat, Michal
NCT04812054: Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death

Recruiting
N/A
104
Europe
Hypothermic oxygenated machine perfusion, DHOPE, Simple cold storage
Medical University of Warsaw, National Science Centre, Poland
Liver Cirrhosis, Liver Tumor, Liver Transplant Failure and Rejection
04/22
04/24
INTERLIVER, NCT03193151: Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting
N/A
300
Europe, Canada, US, RoW
liver biopsy
University of Alberta
Liver Dysfunction
12/25
12/26
Krasnodebski, Maciej
INTERLIVER, NCT03193151: Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting
N/A
300
Europe, Canada, US, RoW
liver biopsy
University of Alberta
Liver Dysfunction
12/25
12/26
Perri, Roman
NCT05677971: Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

Recruiting
3
160
Europe, Canada, US, RoW
Fazirsiran Injection, TAK-999, ARO-AAT, ADS-001, Placebo, Sodium chloride
Takeda, Takeda Development Center Americas, Inc.
Alpha1-Antitrypsin Deficiency
03/27
03/29
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Recruiting
2
200
Europe, Canada, US, RoW
Volixibat, SHP626, Placebo
Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc.
Primary Sclerosing Cholangitis
09/25
12/25
INTERLIVER, NCT03193151: Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting
N/A
300
Europe, Canada, US, RoW
liver biopsy
University of Alberta
Liver Dysfunction
12/25
12/26

Download Options